MXPA04000980A - Tratamiento de hipertension ocular y glaucoma. - Google Patents

Tratamiento de hipertension ocular y glaucoma.

Info

Publication number
MXPA04000980A
MXPA04000980A MXPA04000980A MXPA04000980A MXPA04000980A MX PA04000980 A MXPA04000980 A MX PA04000980A MX PA04000980 A MXPA04000980 A MX PA04000980A MX PA04000980 A MXPA04000980 A MX PA04000980A MX PA04000980 A MXPA04000980 A MX PA04000980A
Authority
MX
Mexico
Prior art keywords
treatment
glaucoma
ocular hypertension
micrograms
keto
Prior art date
Application number
MXPA04000980A
Other languages
English (en)
Spanish (es)
Inventor
Ueno Ryuji
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of MXPA04000980A publication Critical patent/MXPA04000980A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA04000980A 2001-07-31 2002-07-30 Tratamiento de hipertension ocular y glaucoma. MXPA04000980A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30858901P 2001-07-31 2001-07-31
PCT/JP2002/007699 WO2003011299A2 (en) 2001-07-31 2002-07-30 Treatment of ocular hypertension and glaucoma

Publications (1)

Publication Number Publication Date
MXPA04000980A true MXPA04000980A (es) 2004-04-20

Family

ID=23194562

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04000980A MXPA04000980A (es) 2001-07-31 2002-07-30 Tratamiento de hipertension ocular y glaucoma.

Country Status (8)

Country Link
EP (1) EP1411950A2 (enExample)
JP (1) JP2004538306A (enExample)
KR (1) KR20040023707A (enExample)
CN (1) CN1646134A (enExample)
BR (1) BR0211545A (enExample)
CA (1) CA2454422A1 (enExample)
MX (1) MXPA04000980A (enExample)
WO (2) WO2003011299A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082257A2 (en) * 2002-03-28 2003-10-09 Sucampo Ag Method for treating ocular hypertension and glaucoma
AR043161A1 (es) * 2003-02-14 2005-07-20 Sucampo Pharmaceuticals Inc Composicion oftalmica para tratar hipertension ocular y glaucoma
WO2008008701A2 (en) * 2006-07-10 2008-01-17 Allergan, Inc. Substituted cyclopentane derivatives as therapeutic agents
US20080015219A1 (en) * 2006-07-11 2008-01-17 Allergan, Inc. Therapeutic compounds
DK2043993T3 (en) * 2006-07-11 2015-10-12 Allergan Inc Cyclopentane derivatives as anti-glaucoma agents
DK2170345T3 (da) * 2007-07-03 2013-05-13 Allergan Inc Terapeutiske substituerede cyclopentaner til reduktion af intraokulært tryk

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0366279B1 (en) * 1988-10-01 1994-09-21 R-Tech Ueno Ltd. Ocular hypotensive agents
BR0109192A (pt) * 2000-03-16 2003-05-27 Sucampo Ag Tratamento de hipertensão ocular e glaucoma.
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension

Also Published As

Publication number Publication date
EP1411950A2 (en) 2004-04-28
KR20040023707A (ko) 2004-03-18
BR0211545A (pt) 2004-07-13
CA2454422A1 (en) 2003-02-13
WO2003011178A2 (en) 2003-02-13
JP2004538306A (ja) 2004-12-24
CN1646134A (zh) 2005-07-27
WO2003011299A3 (en) 2003-10-30
WO2003011299A2 (en) 2003-02-13

Similar Documents

Publication Publication Date Title
CA2502437A1 (en) Method and composition containing latanoprost for treating ocular hypertension and glaucoma
TWI255713B (en) Method for treating meibomian gland disease
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
BR9808016A (pt) Composições e métodos para redução da hipertensão ocular
MXPA03010146A (es) Composiciones de lipidos hipotensivos (derivados de prostaglandina) y timolol, y metodos para usar las mismas.
AU3056702A (en) Methods and compositions for treatment of ocular neovascularization and neural injury
CA2440764A1 (en) Combination of brimonidine and timolol for topical ophthalmic use
CA2198245A1 (en) Methods and means for drug administration
PT868186E (pt) Utilizacao de certos compostos de isoquinolinossulfonilo para tratamento de glaucoma e isquemia ocular
PL1654002T3 (pl) Kompozycje do dostarczania środków terapeutycznych do oczu
WO2003092584A3 (en) Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
KR101820184B1 (ko) 방부제가 없는 비마토프로스트 및 티몰롤 용액
WO2000018316A3 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
WO2001030380A3 (en) Methods and compositions for treatment of keratoconus using protease inhibitors
AU5446299A (en) Medicinal compositions for treating eye diseases
WO1999043309A3 (en) Anticonvulsant drugs and pharmaceutical compositions thereof
CA2171226A1 (en) Treatment of optic nerve disorder with prostanoic acid compounds
ATE223200T1 (de) Einen carboanhydrase-hemmer und xanthangummi enthaltendes augenarzneimittel
WO2003011299A3 (en) Treatment of ocular hypertension and glaucoma
DK1187611T3 (da) Oftalmiske histaminholdige sammensætninger og anvendelse deraf
AU609807B2 (en) A composition for the topical treatment of glaucoma or ocular hypertension
WO2002072105A3 (en) Improved prostanoid therapies for the treatment of glaucoma
MXPA03010363A (es) Metodo para tratar hipertension ocular y glaucoma.
AU2001267864A1 (en) Remedial agent for optic nerve disease and the like
BR0205932A (pt) Método e composição para tratamento de hipertensão ocular e glaucoma